Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for nicotine dependent pathological gamblers
NCT00967005Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in gambling disorder (GD), Tobacco Use Disorder (TUD), sponsored by University of Chicago. Started Sep 2009; status: completed.
02
Drugs
acetylcysteine
03
Conditions
gambling disorder (GD)Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00967005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00967005.